.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A03C_AntispasmodicsInCombinationWithPsycholeptics.A03CA34_PropanthelineAndPsychole.PropanthelineAndPsychole .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A03C_AntispasmodicsInCombinationWithPsycholeptics.A03CA34_PropanthelineAndPsychole.PropanthelineAndPsychole| name: | PropanthelineAndPsycholeptics | |
| ATC code: | A03CA34 | route: | oral |
| compartments: | 1 | |
| dosage: | 15 | mg |
| volume of distribution: | 2.5 | L |
| clearance: | 0.25 | L/min |
| other parameters in model implementation | ||
Propantheline is an antimuscarinic agent previously used for the treatment of peptic ulcers, irritable bowel syndrome, and other gastrointestinal disorders. The combination 'propantheline and psycholeptics' (A03CA34) refers to fixed-dose medications that include propantheline with psycholeptic drugs, typically for GI disorders with co-occurring anxiety or tension. This combination is not widely used or approved in contemporary therapy.
No published pharmacokinetic studies reporting PK parameters exist for the combination product 'propantheline and psycholeptics'; values below are estimated based on propantheline PK data in healthy adults, oral administration.